On Mon, Sep 12, 2022 at 11:47:07AM +0700, John Naylor wrote:
> I don't think this clarifies anything, it's just a rephrasing.
>
> More broadly, I think the description of varlenas in this header is at
> a kind of "local maximum" -- minor adjustments are more likely to make
> it worse. To significantly improve clarity might require a larger
> rewriting, but I'm not personally interested in taking part in that.
This has remained unanswered for four weeks now, so marked as returned
with feedback in the 2022-09 CF.
--
Michael
